azathioprine has been researched along with Autoimmune Thrombocytopenia in 43 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A diagnosis of autoimmune thrombocytopenia was made." | 6.44 | [Successful treatment with azathioprine for autoimmune thrombocytopenia developing after autologous peripheral blood stem cell transplantation]. ( Fujita, H; Hashimoto, H; Kurata, M; Maeda, A; Mastusita, A; Mori, M; Nagai, K; Nagai, Y; Tabata, S; Takahashi, T; Togami, K, 2007) |
| "First-line AZA plus prednisone realizes a better hematological response and relapse-free duration with acceptable adverse events compared to prednisone alone in ANA-positive ITP patients." | 5.91 | Efficacy and safety of azathioprine plus prednisone versus prednisone alone as first-line treatment for antinuclear antibody-positive immune thrombocytopenia: a retrospective cohort study. ( Chen, X; Dong, Z; Ma, L; Su, J; Wang, Q; Xiao, P; Xu, M, 2023) |
| "We report on four cases (three women, one man, age at diagnosis 26-61 years) with severe autoimmune thrombocytopenia (AITP) who were refractory to initial steroid therapy (n = 4), to subsequent splenectomy (n = 2), azathioprine (n = 1), and cyclosporine (n = 1)." | 3.74 | Late spontaneous remissions in severe adult autoimmune thrombocytopenia. ( Lechner, K; Pabinger, I; Panzer, S; Simanek, R, 2007) |
| "Only few cases of vaccine-induced immune thrombocytopenia or immune hemolysis have been reported so far." | 3.01 | Relapse of Evans syndrome following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine: case report and literature review. ( Cvetković, M; Mitrović, M; Pantić, N; Pravdić, Z; Sabljić, N; Suvajdžić-Vuković, N; Virijević, M, 2023) |
| "Patients with severe immune thrombocytopenic purpura (ITP) may require an acute increase in the platelet count for surgery or ongoing hemorrhage as well as long-term maintenance treatment." | 2.73 | Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP). ( Boruchov, DM; Bussel, JB; Driscoll, MC; Gururangan, S, 2007) |
| "A diagnosis of autoimmune thrombocytopenia was made." | 2.44 | [Successful treatment with azathioprine for autoimmune thrombocytopenia developing after autologous peripheral blood stem cell transplantation]. ( Fujita, H; Hashimoto, H; Kurata, M; Maeda, A; Mastusita, A; Mori, M; Nagai, K; Nagai, Y; Tabata, S; Takahashi, T; Togami, K, 2007) |
| "First-line AZA plus prednisone realizes a better hematological response and relapse-free duration with acceptable adverse events compared to prednisone alone in ANA-positive ITP patients." | 1.91 | Efficacy and safety of azathioprine plus prednisone versus prednisone alone as first-line treatment for antinuclear antibody-positive immune thrombocytopenia: a retrospective cohort study. ( Chen, X; Dong, Z; Ma, L; Su, J; Wang, Q; Xiao, P; Xu, M, 2023) |
| "Selection of patients with chronic immune thrombocytopenia from the French national prospective cohort of pediatric autoimmune cytopenia OBS'CEREVANCE and VIGICAIRE study, treated by splenectomy, hydroxychloroquine, azathioprine, or rituximab as a first second-line treatment." | 1.62 | Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation. ( Abou Chahla, W; Aladjidi, N; Armari-Alla, C; Barlogis, V; Bayart, S; Bertrand, Y; Cheikh, N; Ducassou, S; Fernandes, H; Guitton, C; Kherfellah, D; Laghouati, S; Leblanc, T; Leverger, G; Pasquet, M; Pellier, I; Savel, H; Thiébaut, R; Thomas, C; Vassal, G, 2021) |
| "Severe immune thrombocytopenia complicating pregnancy may require treatment beyond first-line medications (intravenous immunoglobulins or corticosteroids), but there is a paucity of literature on the use of such second-line agents in pregnancy." | 1.56 | Multidrug Therapy for Refractory Immune Thrombocytopenia in Pregnancy. ( Chan, R; Chon, AH; Kwong, K; Lee, RH; Weitz, IC; Wertheimer, FB, 2020) |
| "Azathioprine (AZA) is a commonly used immunosuppressant in patients with autoimmune diseases." | 1.56 | NUDT15 polymorphism explains serious toxicity to azathioprine in Indian patients with chronic immune thrombocytopenia and autoimmune hemolytic anemia: a case series. ( Balasubramanian, P; Devasia, AJ; George, B; Illangeswaran, RSS; Raj, IX, 2020) |
| "Many patients with immune thrombocytopenia (ITP) may require special attention and long-term treatment." | 1.48 | Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice. ( Aboud, N; Depré, F; Mayer, B; Salama, A, 2018) |
| "Interstitial lung disease is a rare but recognised complication of rituximab but has been rarely reported in the setting of ITP." | 1.38 | Rituximab-induced interstitial lung disease in a patient with immune thrombocytopenia purpura. ( Berkahn, L; Child, N; O'Carroll, M, 2012) |
| "Patients with primary immune thrombocytopenia (ITP) may require treatment to reduce the risk of serious bleeding if platelets remain consistently below 30 × 10(9)/L." | 1.36 | Should medical treatment options be exhausted before splenectomy is performed in adult ITP patients? A debate. ( Newland, A; Pabinger, I; Stasi, R; Thornton, P, 2010) |
| "Acute interstitial pneumonitis is the main pulmonary side effect during MTX treatment." | 1.35 | [Pneumonitis associated to methotrexate]. ( Marquina Barcos, A; Monón Ballarín, S; Mozota Duarte, J; Ruiz-Ruiz, FJ; Sáenz Abad, D, 2008) |
| "One patient had immune thrombocytopenia and neutropenia." | 1.33 | Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura. ( Andersen, I; Andersen, TM; Birgens, HS; Bjerrum, OW; Braendstrup, P; Clausen, NT; Hansen, PB; Hasselbalch, HC; Jensen, BA; Nielsen, OJ; Pedersen, BB; Peterslund, NA; Plesner, T; Schmidt, K, 2005) |
| "Sarcoidosis is a chronic granulomatous disorder characterized by multisystem involvement, however, symptomatic thrombocytopenia as a presenting manifestation is rare." | 1.31 | Thrombocytopenia as the presenting manifestation of sarcoidosis. ( Agarwal, A; Agarwal, V; Gupta, RK; Mishra, R; Pal, S, 2002) |
| "Autopsy revealed that the cervical cancer was the primary origin of the liver tumors." | 1.30 | [Rapidly progressive irradiated cervical cancer that metastasized to the liver during therapy for idiopathic thrombocytopenic purpura]. ( Kariya, K; Kawamura, S; Munakata, A; Nakahata, R; Takami, H; Tamai, Y; Tsushima, K; Yoshimura, T, 1999) |
| "A young patient developed chronic idiopathic thrombocytopenic purpura." | 1.28 | Defect of platelet aggregation and adhesion induced by autoantibodies against platelet glycoprotein IIIa. ( Balduini, CL; Bellotti, V; Bertolino, G; Mazzini, G; Noris, P; Piovella, F; Samaden, A; Sinigaglia, F; Torti, M, 1992) |
| "The treatment with azathioprine and prednisolone after IVIG appears to be effective in maintenance of platelet counts." | 1.28 | [Effects of maintenance treatment after high-dose intravenous gamma-globulin for idiopathic thrombocytopenic purpura]. ( Fujitake, H; Im, T; Kageyama, T; Kawagoe, H; Kokawa, T; Nomura, S; Ohyabu, H; Park, K; Tatsumi, N; Yasunaga, K, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.33) | 18.7374 |
| 1990's | 4 (9.30) | 18.2507 |
| 2000's | 17 (39.53) | 29.6817 |
| 2010's | 12 (27.91) | 24.3611 |
| 2020's | 9 (20.93) | 2.80 |
| Authors | Studies |
|---|---|
| Mahajna, H | 3 |
| Verstockt, B | 3 |
| Bergemalm, D | 3 |
| Castiglione, F | 3 |
| Rodríguez-Moranta, F | 3 |
| Savarino, E | 3 |
| Hoentjen, F | 3 |
| Bessissow, T | 3 |
| Pokryszka, J | 3 |
| Cremer, A | 3 |
| Eder, P | 3 |
| Truyens, M | 3 |
| Yerushalmy-Feler, A | 3 |
| García, MJ | 3 |
| Kopylov, U | 3 |
| Su, J | 1 |
| Xu, M | 1 |
| Dong, Z | 1 |
| Wang, Q | 1 |
| Ma, L | 1 |
| Xiao, P | 1 |
| Chen, X | 1 |
| Cvetković, M | 1 |
| Pantić, N | 1 |
| Virijević, M | 1 |
| Pravdić, Z | 1 |
| Sabljić, N | 1 |
| Mitrović, M | 1 |
| Suvajdžić-Vuković, N | 1 |
| Velayos Jiménez, B | 1 |
| Cuello García, R | 1 |
| Del Olmo Martínez, L | 1 |
| Macho Conesa, A | 1 |
| Fernández Salazar, L | 1 |
| Bm, S | 1 |
| Toshniwal, M | 1 |
| Bhattacharya, M | 1 |
| Jakkal, D | 1 |
| Chon, AH | 1 |
| Chan, R | 1 |
| Lee, RH | 1 |
| Kwong, K | 1 |
| Wertheimer, FB | 1 |
| Weitz, IC | 1 |
| Devasia, AJ | 1 |
| Illangeswaran, RSS | 1 |
| Raj, IX | 1 |
| George, B | 1 |
| Balasubramanian, P | 1 |
| Fanouriakis, A | 1 |
| Tziolos, N | 1 |
| Bertsias, G | 1 |
| Boumpas, DT | 1 |
| Ducassou, S | 1 |
| Fernandes, H | 1 |
| Savel, H | 1 |
| Bertrand, Y | 1 |
| Leblanc, T | 1 |
| Abou Chahla, W | 1 |
| Pasquet, M | 1 |
| Leverger, G | 1 |
| Barlogis, V | 1 |
| Thomas, C | 1 |
| Bayart, S | 1 |
| Pellier, I | 1 |
| Armari-Alla, C | 1 |
| Guitton, C | 1 |
| Cheikh, N | 1 |
| Kherfellah, D | 1 |
| Vassal, G | 1 |
| Thiébaut, R | 1 |
| Laghouati, S | 1 |
| Aladjidi, N | 1 |
| Brunet, E | 1 |
| Martínez de Sola, M | 1 |
| Garcia-Iglesias, P | 1 |
| Calvet, X | 1 |
| Depré, F | 1 |
| Aboud, N | 1 |
| Mayer, B | 1 |
| Salama, A | 1 |
| Mizuno, S | 1 |
| Naganuma, M | 1 |
| Kanai, T | 1 |
| Chang, H | 1 |
| Tang, TC | 1 |
| Hung, YS | 1 |
| Li, PL | 1 |
| Kuo, MC | 1 |
| Wu, JH | 1 |
| Wang, PN | 1 |
| Lougaris, V | 1 |
| Baronio, M | 1 |
| Gazzurelli, L | 1 |
| Lorenzini, T | 1 |
| Fuoti, M | 1 |
| Moratto, D | 1 |
| Bozzola, A | 1 |
| Ricci, C | 1 |
| Bondioni, MP | 1 |
| Ravelli, A | 1 |
| Villanacci, V | 1 |
| Plebani, A | 1 |
| Kumwenda, JJ | 1 |
| Hsiao, CH | 1 |
| Tseng, KC | 1 |
| Tseng, CW | 1 |
| Tung, CH | 1 |
| Fan, Y | 1 |
| Chang, NB | 1 |
| Xing, BL | 1 |
| Li, YM | 1 |
| Pei, L | 1 |
| Li, JT | 1 |
| Sabnani, I | 1 |
| Tsang, P | 1 |
| Valdivieso, R | 1 |
| Cevallos, F | 1 |
| Caballero, MT | 1 |
| Quirce, S | 1 |
| Arnold, DM | 1 |
| Nazi, I | 1 |
| Santos, A | 1 |
| Chan, H | 1 |
| Heddle, NM | 1 |
| Warkentin, TE | 1 |
| Kelton, JG | 1 |
| McDonald, EJ | 1 |
| Butler, A | 1 |
| Stasi, R | 1 |
| Newland, A | 1 |
| Thornton, P | 1 |
| Pabinger, I | 2 |
| Child, N | 1 |
| O'Carroll, M | 1 |
| Berkahn, L | 1 |
| Uygur-Bayramiçli, O | 1 |
| Aydin, D | 1 |
| Ak, O | 1 |
| Karadayi, N | 1 |
| RICHMOND, J | 1 |
| WOODRUFF, MF | 1 |
| CUMMING, RA | 1 |
| DONALD, KW | 1 |
| Imbach, P | 1 |
| Tsai, CL | 1 |
| Lu, TC | 1 |
| Chen, WJ | 1 |
| Knecht, H | 1 |
| Baumberger, M | 1 |
| Tobòn, A | 1 |
| Steck, A | 1 |
| Treppendahl, MB | 1 |
| Nielsen, OJ | 2 |
| Braendstrup, P | 1 |
| Bjerrum, OW | 1 |
| Jensen, BA | 1 |
| Clausen, NT | 1 |
| Hansen, PB | 1 |
| Andersen, I | 1 |
| Schmidt, K | 1 |
| Andersen, TM | 1 |
| Peterslund, NA | 1 |
| Birgens, HS | 1 |
| Plesner, T | 1 |
| Pedersen, BB | 1 |
| Hasselbalch, HC | 1 |
| Simanek, R | 1 |
| Panzer, S | 1 |
| Lechner, K | 1 |
| Reale, LD | 1 |
| Besa, EC | 1 |
| Boruchov, DM | 1 |
| Gururangan, S | 1 |
| Driscoll, MC | 1 |
| Bussel, JB | 1 |
| Fujita, H | 1 |
| Togami, K | 1 |
| Mori, M | 1 |
| Hashimoto, H | 1 |
| Nagai, K | 1 |
| Nagai, Y | 1 |
| Tabata, S | 1 |
| Kurata, M | 1 |
| Mastusita, A | 1 |
| Maeda, A | 1 |
| Takahashi, T | 1 |
| Sáenz Abad, D | 1 |
| Ruiz-Ruiz, FJ | 1 |
| Monón Ballarín, S | 1 |
| Mozota Duarte, J | 1 |
| Marquina Barcos, A | 1 |
| Fukuda, M | 1 |
| Horibe, K | 1 |
| Miyajima, Y | 1 |
| Matsumoto, K | 1 |
| Kozaki, T | 1 |
| Komiyama, A | 1 |
| Yoshimura, T | 1 |
| Tamai, Y | 1 |
| Takami, H | 1 |
| Kariya, K | 1 |
| Nakahata, R | 1 |
| Tsushima, K | 1 |
| Munakata, A | 1 |
| Kawamura, S | 1 |
| Ohmine, K | 1 |
| Izumi, T | 1 |
| Muroi, K | 1 |
| Shimizu, R | 1 |
| Imagawa, S | 1 |
| Komatsu, N | 1 |
| Sasaki, R | 1 |
| Hatake, K | 1 |
| Miura, Y | 1 |
| Ozawa, K | 1 |
| Agarwal, V | 1 |
| Pal, S | 1 |
| Agarwal, A | 1 |
| Gupta, RK | 1 |
| Mishra, R | 1 |
| Balduini, CL | 1 |
| Bertolino, G | 1 |
| Noris, P | 1 |
| Piovella, F | 1 |
| Sinigaglia, F | 1 |
| Bellotti, V | 1 |
| Samaden, A | 1 |
| Torti, M | 1 |
| Mazzini, G | 1 |
| Yasunaga, K | 1 |
| Kokawa, T | 1 |
| Fujitake, H | 1 |
| Nomura, S | 1 |
| Kageyama, T | 1 |
| Ohyabu, H | 1 |
| Tatsumi, N | 1 |
| Im, T | 1 |
| Park, K | 1 |
| Kawagoe, H | 1 |
| Sousa, FC | 1 |
| Pinto Medeiros, J | 1 |
| Marques, R | 1 |
| Marques-Neves, C | 1 |
| Matsubara, K | 1 |
| Nigami, H | 1 |
| Harigaya, H | 1 |
| Tanaka, T | 1 |
| Yura, K | 1 |
| Nozaki, H | 1 |
| Iwata, A | 1 |
| Fukaya, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Optimization of Glucocorticoid Taper Strategies for Maintenance Therapy of Systemic Lupus Erythematosus Associated Immune Thrombocytopenia (SLE-ITP)[NCT05506033] | 120 participants (Anticipated) | Interventional | 2022-08-15 | Enrolling by invitation | |||
| "French National Cohort of Patients With Pediatric-onset of Autoimmune Cytopenia (OBS'CEREVANCE Cohort)"[NCT05937828] | 3,500 participants (Anticipated) | Observational [Patient Registry] | 2010-09-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for azathioprine and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
Relapse of Evans syndrome following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine: case report and literature review.
Topics: Anemia, Hemolytic, Autoimmune; Azathioprine; Bilirubin; BNT162 Vaccine; Chronic Disease; COVID-19; C | 2023 |
Update οn the diagnosis and management of systemic lupus erythematosus.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Humanized; Autoantibodies; Azathioprine; Calc | 2021 |
Immune thrombocytopenic purpura associated with Crohn's disease with complete response to infliximab.
Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Azathioprine; Benzoates; Crohn Disease; Humans; Hydra | 2019 |
Refractory idiopathic immune thrombocytopenic purpura in children: current and future treatment options.
Topics: Adult; Antibodies, Monoclonal; Antineoplastic Agents; Azathioprine; Child; Child, Preschool; Cycloph | 2003 |
Rituximab in autoimmune pancytopenia: a case report and review of literature.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived | 2007 |
[Successful treatment with azathioprine for autoimmune thrombocytopenia developing after autologous peripheral blood stem cell transplantation].
Topics: Aged; Azathioprine; Humans; Immunosuppressive Agents; Male; Peripheral Blood Stem Cell Transplantati | 2007 |
3 trials available for azathioprine and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura.
Topics: Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppre | 2010 |
Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Azathioprine; Child; Child, Pr | 2007 |
[Low-dose prednisolone therapy for idiopathic thrombocytopenic purpura].
Topics: Anti-Inflammatory Agents; Azathioprine; Combined Modality Therapy; Humans; Immunosuppressive Agents; | 2000 |
34 other studies available for azathioprine and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
Idiopathic Thrombocytopaenic Purpura associated with Inflammatory Bowel Disease: a multicentre ECCO CONFER case series.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Female; Humans; Inflammatory Bowel Diseases; Male; Pur | 2023 |
Idiopathic Thrombocytopaenic Purpura associated with Inflammatory Bowel Disease: a multicentre ECCO CONFER case series.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Female; Humans; Inflammatory Bowel Diseases; Male; Pur | 2023 |
Idiopathic Thrombocytopaenic Purpura associated with Inflammatory Bowel Disease: a multicentre ECCO CONFER case series.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Female; Humans; Inflammatory Bowel Diseases; Male; Pur | 2023 |
Idiopathic Thrombocytopaenic Purpura associated with Inflammatory Bowel Disease: a multicentre ECCO CONFER case series.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Female; Humans; Inflammatory Bowel Diseases; Male; Pur | 2023 |
Efficacy and safety of azathioprine plus prednisone versus prednisone alone as first-line treatment for antinuclear antibody-positive immune thrombocytopenia: a retrospective cohort study.
Topics: Antibodies, Antinuclear; Azathioprine; Humans; Immunosuppressive Agents; Prednisone; Purpura, Thromb | 2023 |
Immune thrombocytopenic purpura associated with inactive ulcerative colitis in chronic treatment with adalimumab.
Topics: Adalimumab; Anti-Inflammatory Agents; Azathioprine; Blood Transfusion; Colitis, Ulcerative; Female; | 2020 |
Combination Therapy of Azathioprine+ Dapsone as Effective Second Line Agents for the Treatment of Chronic Immune Thrombocytopenic Purpura.
Topics: Anti-Infective Agents; Azathioprine; Combined Modality Therapy; Dapsone; Humans; Immunosuppressive A | 2020 |
Multidrug Therapy for Refractory Immune Thrombocytopenia in Pregnancy.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Pregnancy; | 2020 |
NUDT15 polymorphism explains serious toxicity to azathioprine in Indian patients with chronic immune thrombocytopenia and autoimmune hemolytic anemia: a case series.
Topics: Anemia, Hemolytic, Autoimmune; Azathioprine; Genotype; Humans; Leukopenia; Methyltransferases; Purpu | 2020 |
Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Chronic Disease; Female; Humans; Hydroxychloroqui | 2021 |
Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Benzoates; Child; Child, Preschool; Combin | 2018 |
Idiopathic Thrombocytopenic Purpura Responsive to Surgery for Crohn's Disease.
Topics: Adult; Azathioprine; Crohn Disease; Humans; Immunosuppressive Agents; Male; Prognosis; Purpura, Thro | 2019 |
Immune thrombocytopenia: Effectiveness of frontline steroids and comparison of azathioprine, splenectomy, and rituximab as second-line treatment.
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Biomarkers; Combined Modality Therapy; Female; Humans; | 2018 |
A de novo monoallelic CTLA-4 deletion causing pediatric onset CVID with recurrent autoimmune cytopenias and severe enteropathy.
Topics: Adalimumab; Adolescent; Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Autoimmune Diseases | 2018 |
A woman with recurrent anaemia and the Malawian health system.
Topics: Anemia, Hemolytic; Antibodies, Antinuclear; Azathioprine; Clinical Laboratory Services; Coombs Test; | 2013 |
Late-Onset Immune Thrombocytopenic Purpura After Withdrawal of Interferon Treatment for Chronic Hepatitis C Infection: A Case Report.
Topics: Age of Onset; Antiviral Agents; Azathioprine; Glucocorticoids; Hepatitis C, Chronic; Humans; Immunos | 2015 |
[A clinical study of 103 idiopathic thrombocytopenic purpura].
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Azathioprine; China; Cyclophosphamide; Cyc | 2008 |
Therapeutic implications of T-cell clonopathy of unknown significance in chronic immune thrombocytopenic purpura.
Topics: Adult; Aged; Azathioprine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Purpura, Thr | 2009 |
Chronic urticaria caused by folic acid.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Azathioprine; Drug Hypersensitivity; Female; Folic Acid; Humans | 2009 |
Immune thrombocytopaenia in adults: a single-centre retrospective review of patients presenting over 7 years.
Topics: Adult; Antibodies, Antinuclear; Antineoplastic Agents, Phytogenic; Azathioprine; Biopsy, Fine-Needle | 2010 |
Should medical treatment options be exhausted before splenectomy is performed in adult ITP patients? A debate.
Topics: Adrenal Cortex Hormones; Azathioprine; Danazol; Humans; Purpura, Thrombocytopenic, Idiopathic; Recep | 2010 |
Rituximab-induced interstitial lung disease in a patient with immune thrombocytopenia purpura.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Combined Modality Therapy; | 2012 |
Hyperprolactinemia caused by azathioprine.
Topics: Adult; Azathioprine; Female; Hepatitis, Autoimmune; Humans; Hyperprolactinemia; Immunosuppressive Ag | 2003 |
A case of idiopathic thrombocytopenia and autoimmune hemolytic anemia treated with thymic irradiation and by administration of imuran and actinomycin-C.
Topics: Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune; Autoimmune Diseases; Azathioprine; Dactinomycin; H | 1963 |
Spontaneous retroperitoneal bleeding in a patient with Evans syndrome.
Topics: Adult; Anemia, Hemolytic; Angiography; Anti-Inflammatory Agents; Antimetabolites; Azathioprine; Fema | 2004 |
Sustained remission of CIDP associated with Evans syndrome.
Topics: Adrenal Cortex Hormones; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclon | 2004 |
[Idiopathic thrombocytopenic purpura. A retrospective evaluation of 68 patients].
Topics: Adult; Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Azathioprine; Cyclophospha | 2004 |
Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-D | 2005 |
Late spontaneous remissions in severe adult autoimmune thrombocytopenia.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cohort Studies; Cyclosporine; Female; Humans; Im | 2007 |
[Pneumonitis associated to methotrexate].
Topics: Adrenal Cortex Hormones; Azathioprine; Diagnosis, Differential; Female; Humans; Immunosuppressive Ag | 2008 |
[Chronic myelomonocytic leukemia developed 9 years after the diagnosis of idiopathic thrombocytopenic purpura in a child].
Topics: Adolescent; Azathioprine; Combined Modality Therapy; Female; Humans; Leukemia, Myelomonocytic, Chron | 1994 |
[Rapidly progressive irradiated cervical cancer that metastasized to the liver during therapy for idiopathic thrombocytopenic purpura].
Topics: Adult; Azathioprine; Carcinoma, Squamous Cell; Disease Progression; Female; Humans; Immunosuppressiv | 1999 |
Thrombocytopenia as the presenting manifestation of sarcoidosis.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Female; Humans; Immunosuppressive Agents; Purpura, Thr | 2002 |
Defect of platelet aggregation and adhesion induced by autoantibodies against platelet glycoprotein IIIa.
Topics: Adult; Autoantibodies; Azathioprine; Blood Platelet Disorders; Female; Humans; Platelet Adhesiveness | 1992 |
[Effects of maintenance treatment after high-dose intravenous gamma-globulin for idiopathic thrombocytopenic purpura].
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Combined Modality Therapy; Female; gamma-Globulins; Hu | 1991 |
Spontaneous retrobulbar haemorrhage in idiopathic thrombocytopenic purpura.
Topics: Adrenal Cortex Hormones; Aged, 80 and over; Humans; Intraocular Pressure; Male; Mercaptopurine; Purp | 2017 |
[Combination therapy with low-dose cyclosporin A, azathiopurine, and prednisolone for a child with refractory chronic idiopathic thrombocytopenic purpura].
Topics: Child, Preschool; Chronic Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combina | 2007 |